Nucleic acids, proteins, and antibodies
CA 2392757 A1 · Owner: Barash, Steven C. · Inventors: Rosen, Craig A.; Barash, Steven C.; Ruben, Steven M.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to novel pancreatic related polynucleotides and the polypeptides encoded by these polynucleotides herein collectively known as "pancreatic antigens", and the use of such pancreatic antigens for detecting disorders of the pancreas, particularly the presence of pancreatic cancer and pancreatic cancer metastases. More specifically isolated pancreatic , associated nucleic acid molecules are provided encoding novel pancreatic associated polypeptides. Novel pancreatic polypeptides and antibodies that bind to these polypeptides are provided. Also provided are vectors host , cells, and recombinant and synthetic methods for producing human pancreatic associated …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 17, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 17, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 17, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.